抗菌薬感受性検査の市場規模、シェア、動向分析レポート製品別、手法別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

抗菌薬感受性検査市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界の抗菌薬感受性検査市場規模は、2023年から2030年まで5.1%のCAGRで拡大し、2030年までに50億8,000万米ドルに達すると予測されています。

この成長は主に、技術の進歩による機会の拡大、主要参入企業による研究開発活動の増加、診断と効果的な治療法の特定における抗菌薬感受性検査（AST）の浸透の増加に起因しています。さらに、創薬・開発、臨床検査室での感受性検査、個別化医療など、さまざまな用途で抗菌薬感受性検査の採用が増加していることも、成長を促進する主要因となっています。

また、適切な衛生管理の欠如や不衛生な食生活により、肺炎や血流感染症などの感染症が増加していることも、予測期間中の成長をさらに後押ししています。さらに、AMR対策として政府機関が行っている有利なイニシアチブは、予測期間中に抗菌薬感受性検査の需要を押し上げると予想されています。例えば、米国政府は2020年10月に、感染予防を優先し、これらの疾患の治療における抗生物質の使用を最適化することで医療サービスを改善するための「抗生物質耐性菌と闘うための国家行動計画（CARB）2020-2025」を更新しています。

さらに、M&Aや新製品の発売など、さまざまな戦略的イニシアティブに対する主要企業の注目度が高まっていることが、予測期間中の市場成長をさらに促進すると予想されます。例えば、2022年5月、Qualigen Therapeuticsは、NanoSynexの株式の過半数を取得する契約を締結しました。NanoSynexは、患者の感染症に対する抗生物質の迅速な特定を支援するASTプラットフォームを開発しました。このような取り組みにより、今後数年間は成長が期待されます。

全体として、COVID-19のパンデミックは、サプライチェーンの混乱や世界中の政府機関による規制により、AST業界に悪影響を及ぼしました。しかし、COVID-19は市場に新たな機会をもたらしました。多くの研究が、抗菌薬感受性検査がCOVID-19疾患の治療に最適な抗生物質をより短いスパンで見つけるのに役立つと述べています。米国国立医学図書館によると、直接迅速抗生物質感受性検査（dRAST）は、COVID-19患者の菌血症に対する早期かつ最適な抗生物質治療を可能にするのに役立ちます。

しかし、技術的に高度な製品や自動化された機器のコストが高いこと、臨床的ブレイクポイントの決定や新規抗菌薬の承認に時間がかかること、これらの製品の複雑な承認プロセスなどの要因が、予測期間中の市場成長の妨げとなる可能性があります。

抗菌薬感受性検査市場レポートハイライト：

• 世界の抗菌薬感受性検査産業は、2022年に34億米ドルとなり、予測期間には5.1%のCAGRで成長すると予測されます。
• 2022年には手動検査分野が53.27%の最大シェアを占めました。市場成長の要因は、自動化されたテストと比較して、入手が容易であり、コストが低いことです。しかし、自動テストは予測期間中、最も速いCAGR主導の成長を記録すると予測されます。
• 技術に基づくと、ディスク拡散セグメントが2022年の市場を独占しました。この成長は、柔軟性や費用対効果などのさまざまな利点に起因していると考えられます。しかし、自動ASTは予測期間中に最も速いCAGRで成長すると予測されます。
• 病院セグメントは、AMR＆HAI症例の増加や個別化医療のためのASTの採用拡大により、2022年にAST業界を支配しました。
• バイオテクノロジーおよび製薬会社は、創薬への関心の高まりにより、予測期間中に最も速い成長率を示すと予測されます。
• 2022年の世界市場は北米が支配しています。業界成長の主な要因は、技術的に高度な製品を容易に入手できること、個別化医療の採用が進んでいることです。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメント範囲
  • 地域範囲
  • 推定・予測のタイムライン
• 調査手法
• 情報調達
  • 購入したデータベース：
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー分析
    • アプローチ：コモディティフローアプローチ
• 調査の仮定
• 二次情報のリスト
• 略語のリスト
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察

第3章 抗菌薬感受性検査市場の変数、動向、および範囲

• 市場系統の見通し
  • 親市場
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 普及と成長の見通しマッピング
• 抗菌剤感受性検査：市場分析ツール
  • 業界分析- ポーターズ
  • PESTLE分析
• 規制の枠組み

第4章 抗菌薬感受性検査市場セグメント分析、製品別、2018年～2030年

• 定義と範囲
• 製品市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 世界の抗菌薬感受性検査市場、製品別、2018年から2030年
• 2018年から2030年の市場規模、予測、傾向分析
  • 手動検査
    • MICストリップ
    • 感受性検査用ディスク
    • 磁化率プレート
  • 自動機器
  • 消耗品とメディア

第5章 抗菌薬感受性検査市場セグメント分析、技術別、2018年～2030年

• 定義と範囲
• 技術市場シェア分析、2022年および2030年
• 技術セグメントダッシュボード
• 世界の抗菌薬感受性検査市場、技術別、2018年から2030年
• 2018年から2030年の市場規模、予測、傾向分析
  • 自動化AST
  • Eテスト方法
  • 希釈
  • ディスクの拡散
  • その他

第6章 抗菌薬感受性検査市場セグメント分析、用途別、2018年～2030年

• 定義と範囲
• アプリケーション市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 世界の抗菌薬感受性検査市場、用途別、2018年から2030年
• 2018年から2030年の市場規模、予測、傾向分析
  • 医薬品開発
  • 感受性検査
  • その他

第7章 抗菌薬感受性検査市場セグメント分析、エンドユース別、2018年～2030年

• 定義と範囲
• アプリケーション市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 世界の抗菌薬感受性検査市場、エンドユース別、2018年から2030年
• 2018年から2030年の市場規模、予測、傾向分析
  • 製薬会社およびバイオテクノロジー会社
  • 診断研究所
  • 病院
  • その他

第8章 抗菌薬感受性検査市場セグメント分析、地域別、2018年～2030年

• 定義と範囲
• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、収益および傾向分析、2022年から2030年まで
  • 北米
    • 米国
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • カナダ
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • 欧州
    • 英国
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • ドイツ
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • スペイン
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • フランス
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • イタリア
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • デンマーク
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • スウェーデン
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • ノルウェー
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • アジア太平洋地域
    • 日本
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • 中国
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • インド
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • 韓国
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • オーストラリア
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • タイ
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • ラテンアメリカ
    • ブラジル
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • メキシコ
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • アルゼンチン
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
  • MEA
    • 南アフリカ
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • サウジアラビア
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • アラブ首長国連邦
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ
    • クウェート
    • 主要な国の動向
    • 競合シナリオ
    • 規制の枠組み
    • 償還シナリオ

第9章 抗菌薬感受性検査市場- 競争分析

• 主要市場参入企業別最近の動向と影響分析
  • Ansoff matrix
  • Heat map analysis
  • Major Deals and Strategic Alliances Analysis
• 会社の分類
  • イノベーター
  • マーケットリーダー
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
• 公開会社
  • 競合ダッシュボード分析
• 非公開会社
  • 主要な新興企業のリスト
• 企業プロファイル
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • BD
  • BIOMERIEUX
  • Creative Diagnostics
  • Hi-Media Laboratories Pvt. Ltd.
  • PerkinElmer, Inc.
  • ELITechGroup
  • F. Hoffmann-La Roche Ltd

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 4 Global antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 5 Global antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 6 Global antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 7 Global antimicrobial susceptibility testing market, by region, 2018 - 2030 (USD Million)
• Table 8 North America antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
• Table 9 North America antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 10 North America antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 11 North America antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 12 North America antimicrobial susceptibility testing market, by end-use, 2018-20
• Table 13 U.S. antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 14 U.S. antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 15 U.S. antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 16 U.S. antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 17 Canada antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 18 Canada antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 19 Canada antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 20 Canada antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 21 Europe antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
• Table 22 Europe antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 23 Europe antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 24 Europe antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 25 Europe antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 26 U.K. antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 27 U.K. antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 28 U.K. antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 29 U.K. antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 30 Germany antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 31 Germany antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 32 Germany antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 33 Germany antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 34 France antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 35 France antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 36 France antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 37 France antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 38 Italy antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 39 Italy antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 40 Italy antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 41 Italy antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 42 Spain antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 43 Spain antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 44 Spain antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 45 Spain antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 46 Sweden antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 47 Sweden antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 48 Sweden antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 49 Sweden antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 50 Denmark antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 51 Denmark antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 52 Denmark antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 53 Denmark antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 54 Norway antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 55 Norway antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 56 Norway antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 57 Norway antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 63 Japan antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 64 Japan antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 65 Japan antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 66 Japan antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 67 India antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 68 India antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 69 India antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 70 India antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 71 China antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 72 China antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 73 China antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 74 China antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 75 Australia antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 76 Australia antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 77 Australia antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 78 Australia antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 79 South Korea antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 80 South Korea antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 81 South Korea antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 82 South Korea antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 83 Thailand antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 84 Thailand antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 85 Thailand antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 86 Thailand antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 87 Latin America antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
• Table 88 Latin America antimicrobial susceptibility testing market, by product, 2018 - 2030 (USD Million)
• Table 89 Latin America antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 90 Latin America antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 91 Latin America antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 92 Brazil antimicrobial susceptibility testing market, by product types, 2018 - 2030 (USD Million)
• Table 93 Brazil antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 94 Brazil antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 95 Brazil antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 96 Mexico antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 97 Mexico antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 98 Mexico antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 99 Mexico antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 100 Argentina antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 101 Argentina antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 102 Argentina antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 103 Argentina antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa antimicrobial susceptibility testing market, by country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 109 South Africa antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 110 South Africa antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 111 South Africa antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 112 South Africa antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 117 UAE antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 118 UAE antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 119 UAE antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 120 UAE antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 121 Kuwait antimicrobial susceptibility testing market, by product type, 2018 - 2030 (USD Million)
• Table 122 Kuwait antimicrobial susceptibility testing market, by technique, 2018 - 2030 (USD Million)
• Table 123 Kuwait antimicrobial susceptibility testing market, by application, 2018 - 2030 (USD Million)
• Table 124 Kuwait antimicrobial susceptibility testing market, by end-use, 2018 - 2030 (USD Million)
• Table 125 Participant's overview
• Table 126 Financial performance
• Table 127 Key Companies undergoing Expansions.
• Table 128 Key Companies Undertaking Acquisitions.
• Table 129 Key Companies Undergoing Collaborations.
• Table 130 Key Companies Launching New Products/Services
• Table 131 Key Companies Undergoing Partnerships.
• Table 132 Key Companies Undergoing Other Strategies

List of Figures

• Fig. 1 Antimicrobial susceptibility testing market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Antimicrobial susceptibility testing market driver analysis
• Fig. 13 Antimicrobial susceptibility testing market restraint analysis
• Fig. 14 Antimicrobial susceptibility testing market: Porter's analysis
• Fig. 15 Antimicrobial susceptibility testing market: PESTLE analysis
• Fig. 16 Antimicrobial susceptibility testing market: Product outlook and key takeaways
• Fig. 17 Antimicrobial susceptibility testing market: Product market share analysis, 2022 - 2030
• Fig. 18 Global manual tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Global automated instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Global consumables & media market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Antimicrobial susceptibility testing market: Technique outlook and key takeaways
• Fig. 22 Antimicrobial susceptibility testing market: Technique market share analysis, 2022 - 2030
• Fig. 23 Global automated AST market, 2018 - 2030 (USD million)
• Fig. 24 Global Etest method market, 2018 - 2030 (USD million)
• Fig. 25 Global dilution market, 2018 - 2030 (USD million)
• Fig. 26 Global disk diffusion market, 2018 - 2030 (USD million)
• Fig. 27 Global others market, 2018 - 2030 (USD million)
• Fig. 28 Global incident management market, 2018 - 2030 (USD million)
• Fig. 29 Antimicrobial susceptibility testing market: application outlook and key takeaways
• Fig. 30 Antimicrobial susceptibility testing market: application market share analysis, 2022 - 2030
• Fig. 31 Global drug development market, 2018 - 2030 (USD million)
• Fig. 32 Global susceptibility testing clinics market, 2018 - 2030 (USD million)
• Fig. 33 Global others market, 2018 - 2030 (USD million)
• Fig. 34 Antimicrobial susceptibility testing market: End-use outlook and key takeaways
• Fig. 35 Antimicrobial susceptibility testing market: End-use market share analysis, 2022 - 2030
• Fig. 36 Global hospitals market, 2018 - 2030 (USD million)
• Fig. 37 Global diagnostic laboratories market, 2018 - 2030 (USD million)
• Fig. 38 Global diagnostic biotechnology & pharmaceutical market, 2018 - 2030 (USD million)
• Fig. 39 Global others market, 2018 - 2030 (USD million)
• Fig. 40 Regional marketplace: Key takeaways
• Fig. 41 North America antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 42 U.S. antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 43 U.S.: Country dynamics
• Fig. 44 Canada antimicrobial susceptibility testing market, 2018 - 2030 (USD million)
• Fig. 45 Canada: Country dynamics
• Fig. 46 Europe antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 U.K. antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 U.K.: Country dynamics
• Fig. 49 Germany antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Germany: Country dynamics
• Fig. 51 France antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 France: Country dynamics
• Fig. 53 Italy antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Italy: Country dynamics
• Fig. 55 Spain antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Spain: Country dynamics
• Fig. 57 Denmark antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Denmark: Country dynamics
• Fig. 59 Sweden antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Sweden: Country dynamics
• Fig. 61 Norway antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Norway: Country dynamics
• Fig. 63 Asia-Pacific antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Japan antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Japan: Country dynamics
• Fig. 66 China antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 China: Country dynamics
• Fig. 68 India antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 India: Country dynamics
• Fig. 70 Australia antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Australia: Country dynamics
• Fig. 72 Thailand antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Thailand: Country dynamics
• Fig. 74 South Korea antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 South Korea: Country dynamics
• Fig. 76 Latin America antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Brazil antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Brazil: Country dynamics
• Fig. 79 Mexico antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Mexico: Country dynamics
• Fig. 81 Argentina antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Argentina: Country dynamics
• Fig. 83 MEA antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 South Africa antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 South Africa: Country dynamics
• Fig. 86 Saudi Arabia antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Saudi Arabia: Country dynamics
• Fig. 88 UAE antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 UAE: Country dynamics
• Fig. 90 Kuwait antimicrobial susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Kuwait: Country dynamics
• Fig. 92 Key company categorization
• Fig. 93 Company market share analysis
• Fig. 94 Company market position analysis
• Fig. 95 Market participant categorization
• Fig. 96 Strategy framework

Antimicrobial Susceptibility Testing Market Growth & Trends:

The global antimicrobial susceptibility testing market size is expected to reach USD 5.08 billion by 2030, expanding at 5.1% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is primarily attributed to the growing opportunities owing to advancement in technology, increasing R&D activities by leading participants, and increasing penetration of antimicrobial susceptibility testing (AST) in diagnosis and identification of effective treatment options. In addition, the increasing adoption of antimicrobial susceptibility testing in various applications such as drug discovery & development, susceptibility testing in clinical laboratories, and personalized medicine are the leading factors propelling growth.

The increasing prevalence of infectious diseases such as pneumonia and bloodstream infections due to a lack of proper sanitization and an unhygienic diet is further boosting the growth over the forecast period. Moreover, favorable initiatives undertaken by government bodies to combat AMR is anticipated to boost the demand for antimicrobial susceptibility testing over the forecast period. For instance, in October 2020, the U.S. government updated its National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025 to improve health services by prioritizing infection prevention and optimizing the use of antibiotics in the treatment of these diseases.

Moreover, the rising focus of key players on various strategic initiatives such as mergers & acquisitions and the launching of new products is further expected to drive the market growth over the forecast period. For instance, in May 2022, Qualigen Therapeutics entered into an agreement to acquire a majority stake in NanoSynex. NanoSynex has developed an AST platform to help faster identification of antibiotics for patient infections. Such initiatives are expected to increase growth in the coming years.

Overall, the COVID-19 pandemic impacted the AST industry adversely due to disruption in the supply chain and restrictions imposed by government bodies across the globe. However, COVID-19 opened new opportunities for the market, as many studies stated that antimicrobial susceptibility testing helps find optimal antibiotics in a shorter span for treating COVID-19 disease. According to the National Library of Medicine, a direct rapid antibiotic susceptibility test (dRAST) helps enable earlier & optimal antibiotic treatments for bacteremia in COVID-19 patients.

However, factors such as the high cost of technologically advanced products & automated instruments, the time gap determining clinical breakpoints, approving novel antimicrobial drugs, and the complex approval process of these products may hamper the market growth over the forecast period.

Antimicrobial Susceptibility Testing Market Report Highlights:

• The global antimicrobial susceptibility testing industry was valued at USD 3.4 billion in 2022 and is projected to grow at a CAGR of 5.1% over the forecast period

• Manual testing segment held the largest share of 53.27% in 2022. The market growth is attributed to the ease of availability and lower cost as compared to automated testing. However, automated testing is projected to register the fastest CAGR-driven growth over the forecast period

• Based on technique, the disk diffusion segment dominated the market in 2022. The growth can be attributed to various advantages such as flexibility and cost-effectiveness. However, automated AST is projected to grow at the fastest CAGR during the forecast period

• Hospital segment dominated the AST industry in 2022 due to increasing AMR & HAIs cases and the growing adoption of AST for personalized medicine

• Biotechnology & pharmaceutical companies are projected to showcase the fastest growth rate over the forecast period due to a rising focus on drug discovery

• North America dominated the global market in 2022. The major factors that attribute the industry growth are the easy availability of technologically advanced products and the rising adoption of personalized medicine

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Antimicrobial Susceptibility Testing Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Market Dynamics
  • 3.2.1 Market drivers analysis
  • 3.2.2 Market restraint analysis
• 3.3 Penetration & Growth Prospect Mapping
• 3.4 Antimicrobial Susceptibility Testing: Market Analysis Tools
  • 3.4.1 Industry analysis - Porter's
  • 3.4.2 PESTLE analysis
• 3.5 Regulatory Framework

Chapter 4 Antimicrobial Susceptibility Testing Market Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Product Market Share Analysis, 2022 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Antimicrobial Susceptibility Testing Market, by Product, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 Manual Tests
    • 4.5.1.1 Manual Tests market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.1.2 MIC Strips
    • 4.5.1.2.1 MIC Strips market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.1.3 Susceptibility Testing Disks
    • 4.5.1.3.1 Susceptibility Testing Disks market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.1.4 Susceptibility Plates
    • 4.5.1.4.1 Susceptibility Plates market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.2 Automated Instruments
    • 4.5.2.1 Automated Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.3 Consumables & Media
    • 4.5.3.1 Consumables & Media market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Antimicrobial Susceptibility Testing Market Segment Analysis, By Technique 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Technique Market Share Analysis, 2022 & 2030
• 5.3 Technique Segment Dashboard
• 5.4 Global Antimicrobial Susceptibility Testing Market, by Technique, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Automated AST
    • 5.5.1.1 Automated AST market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.2 Etest Method
    • 5.5.2.1 Etest Method market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.3 Dilution
    • 5.5.3.1 Dilution estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.4 Disk Diffusion
    • 5.5.4.1 Disk Diffusion market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.5 Others
    • 5.5.5.1 Others estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Antimicrobial Susceptibility Testing Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 Application Market Share Analysis, 2022 & 2030
• 6.3 Segment Dashboard
• 6.4 Global Antimicrobial Susceptibility Testing Market, by Application, 2018 to 2030
• 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.5.1 Drug Development
    • 6.5.1.1 Drug development market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.2 Susceptibility Testing
    • 6.5.2.1 Susceptibility testing market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3 Others
    • 6.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Antimicrobial Susceptibility Testing Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)

• 7.1 Definition and Scope
• 7.2 Application Market Share Analysis, 2022 & 2030
• 7.3 Segment Dashboard
• 7.4 Global Antimicrobial Susceptibility Testing Market, by End-Use, 2018 to 2030
• 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 7.5.1 Pharmaceutical & biotechnology companies
    • 7.5.1.1 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.2 Diagnostic Laboratories
    • 7.5.2.1 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.3 Hospitals
    • 7.5.3.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.4 Others
    • 7.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Antimicrobial Susceptibility Testing Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 8.1 Definition & Scope
• 8.2 Regional Market Share Analysis, 2022 & 2030
• 8.3 Regional Market Dashboard
• 8.4 Regional Market Snapshot
• 8.5 SWOT Analysis
  • 8.5.1 North America
  • 8.5.2 Europe
  • 8.5.3 Asia Pacific
  • 8.5.4 Latin America
  • 8.5.5 Middle East & Africa
• 8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
  • 8.6.1 North America
    • 8.6.1.1 North America Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.1.2 U.S.
    • 8.6.1.2.1 Key Country Dynamics
    • 8.6.1.2.2 Competitive Scenario
    • 8.6.1.2.3 Regulatory Framework
    • 8.6.1.2.4 Reimbursement Scenario
    • 8.6.1.2.5 U.S. Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.1.3 Canada
    • 8.6.1.3.1 Key Country Dynamics
    • 8.6.1.3.2 Competitive Scenario
    • 8.6.1.3.3 Regulatory Framework
    • 8.6.1.3.4 Reimbursement Scenario
    • 8.6.1.3.5 Canada Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6.2 Europe
    • 8.6.2.1 Europe Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.2 U.K.
    • 8.6.2.2.1 Key Country Dynamics
    • 8.6.2.2.2 Competitive Scenario
    • 8.6.2.2.3 Regulatory Framework
    • 8.6.2.2.4 Reimbursement Scenario
    • 8.6.2.2.5 U.K. Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.3 Germany
    • 8.6.2.3.1 Key Country Dynamics
    • 8.6.2.3.2 Competitive Scenario
    • 8.6.2.3.3 Regulatory Framework
    • 8.6.2.3.4 Reimbursement Scenario
    • 8.6.2.3.5 Germany Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.4 Spain
    • 8.6.2.4.1 Key Country Dynamics
    • 8.6.2.4.2 Competitive Scenario
    • 8.6.2.4.3 Regulatory Framework
    • 8.6.2.4.4 Reimbursement Scenario
    • 8.6.2.4.5 Spain Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.5 France
    • 8.6.2.5.1 Key Country Dynamics
    • 8.6.2.5.2 Competitive Scenario
    • 8.6.2.5.3 Regulatory Framework
    • 8.6.2.5.4 Reimbursement Scenario
    • 8.6.2.5.5 France Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.6 Italy
    • 8.6.2.6.1 Key Country Dynamics
    • 8.6.2.6.2 Competitive Scenario
    • 8.6.2.6.3 Regulatory Framework
    • 8.6.2.6.4 Reimbursement Scenario
    • 8.6.2.6.5 Italy Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.7 Denmark
    • 8.6.2.7.1 Key Country Dynamics
    • 8.6.2.7.2 Competitive Scenario
    • 8.6.2.7.3 Regulatory Framework
    • 8.6.2.7.4 Reimbursement Scenario
    • 8.6.2.7.5 Denmark Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.8 Sweden
    • 8.6.2.8.1 Key Country Dynamics
    • 8.6.2.8.2 Competitive Scenario
    • 8.6.2.8.3 Regulatory Framework
    • 8.6.2.8.4 Reimbursement Scenario
    • 8.6.2.8.5 Sweden Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2.9 Norway
    • 8.6.2.9.1 Key Country Dynamics
    • 8.6.2.9.2 Competitive Scenario
    • 8.6.2.9.3 Regulatory Framework
    • 8.6.2.9.4 Reimbursement Scenario
    • 8.6.2.9.5 Norway Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6.3 Asia Pacific
    • 8.6.3.1 Asia Pacific Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3.2 Japan
    • 8.6.3.2.1 Key Country Dynamics
    • 8.6.3.2.2 Competitive Scenario
    • 8.6.3.2.3 Regulatory Framework
    • 8.6.3.2.4 Reimbursement Scenario
    • 8.6.3.2.5 Japan Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3.3 China
    • 8.6.3.3.1 Key Country Dynamics
    • 8.6.3.3.2 Competitive Scenario
    • 8.6.3.3.3 Regulatory Framework
    • 8.6.3.3.4 Reimbursement Scenario
    • 8.6.3.3.5 China Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3.4 India
    • 8.6.3.4.1 Key Country Dynamics
    • 8.6.3.4.2 Competitive Scenario
    • 8.6.3.4.3 Regulatory Framework
    • 8.6.3.4.4 Reimbursement Scenario
    • 8.6.3.4.5 India Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3.5 South Korea
    • 8.6.3.5.1 Key Country Dynamics
    • 8.6.3.5.2 Competitive Scenario
    • 8.6.3.5.3 Regulatory Framework
    • 8.6.3.5.4 Reimbursement Scenario
    • 8.6.3.5.5 South Korea Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3.6 Australia
    • 8.6.3.6.1 Key Country Dynamics
    • 8.6.3.6.2 Competitive Scenario
    • 8.6.3.6.3 Regulatory Framework
    • 8.6.3.6.4 Reimbursement Scenario
    • 8.6.3.6.5 Australia Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3.7 Thailand
    • 8.6.3.7.1 Key Country Dynamics
    • 8.6.3.7.2 Competitive Scenario
    • 8.6.3.7.3 Regulatory Framework
    • 8.6.3.7.4 Reimbursement Scenario
    • 8.6.3.7.5 Thailand Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6.4 Latin America
    • 8.6.4.1 Latin America Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4.2 Brazil
    • 8.6.4.2.1 Key Country Dynamics
    • 8.6.4.2.2 Competitive Scenario
    • 8.6.4.2.3 Regulatory Framework
    • 8.6.4.2.4 Reimbursement Scenario
    • 8.6.4.2.5 Brazil Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4.3 Mexico
    • 8.6.4.3.1 Key Country Dynamics
    • 8.6.4.3.2 Competitive Scenario
    • 8.6.4.3.3 Regulatory Framework
    • 8.6.4.3.4 Reimbursement Scenario
    • 8.6.4.3.5 Mexico Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4.4 Argentina
    • 8.6.4.4.1 Key Country Dynamics
    • 8.6.4.4.2 Competitive Scenario
    • 8.6.4.4.3 Regulatory Framework
    • 8.6.4.4.4 Reimbursement Scenario
    • 8.6.4.4.5 Argentina Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6.5 MEA
    • 8.6.5.1 MEA Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5.2 South Africa
    • 8.6.5.2.1 Key Country Dynamics
    • 8.6.5.2.2 Competitive Scenario
    • 8.6.5.2.3 Regulatory Framework
    • 8.6.5.2.4 Reimbursement Scenario
    • 8.6.5.2.5 South Africa Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5.3 Saudi Arabia
    • 8.6.5.3.1 Key Country Dynamics
    • 8.6.5.3.2 Competitive Scenario
    • 8.6.5.3.3 Regulatory Framework
    • 8.6.5.3.4 Reimbursement Scenario
    • 8.6.5.3.5 Saudi Arabia Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5.4 UAE
    • 8.6.5.4.1 Key Country Dynamics
    • 8.6.5.4.2 Competitive Scenario
    • 8.6.5.4.3 Regulatory Framework
    • 8.6.5.4.4 Reimbursement Scenario
    • 8.6.5.4.5 UAE Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5.5 Kuwait
    • 8.6.5.5.1 Key Country Dynamics
    • 8.6.5.5.2 Competitive Scenario
    • 8.6.5.5.3 Regulatory Framework
    • 8.6.5.5.4 Reimbursement Scenario
    • 8.6.5.5.5 Kuwait Antimicrobial Susceptibility Testing market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Antimicrobial Susceptibility Testing Market - Competitive Analysis

• 9.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.1.1 Ansoff matrix
  • 9.1.2 Heat map analysis
  • 9.1.3 Major Deals and Strategic Alliances Analysis
    • 9.1.3.1 Joint Ventures
    • 9.1.3.2 Licensing Agreements
    • 9.1.3.3 Product Launches
    • 9.1.3.4 Conferences and Campaigns
• 9.2 Company Categorization
  • 9.2.1 Innovators
  • 9.2.2 Market Leaders
• 9.3 Vendor Landscape
  • 9.3.1 List of key distributors and channel partners
  • 9.3.2 Key customers
• 9.4 Public Companies
  • 9.4.1 Competitive Dashboard Analysis
    • 9.4.1.1 Market Differentiators
• 9.5 Private Companies
  • 9.5.1 List of key emerging companies
• 9.6 Company Profiles
  • 9.6.1 Bio-Rad Laboratories Inc.
    • 9.6.1.1 Company overview
    • 9.6.1.2 Financial performance
    • 9.6.1.3 Product benchmarking
    • 9.6.1.4 Strategic Initiatives
  • 9.6.2 Thermo Fisher Scientific Inc.
    • 9.6.2.1 Company overview
    • 9.6.2.2 Financial performance
    • 9.6.2.3 Product benchmarking
    • 9.6.2.4 Strategic Initiatives
  • 9.6.3 Danaher Corporation
    • 9.6.3.1 Company overview
    • 9.6.3.2 Financial performance
    • 9.6.3.3 Product benchmarking
    • 9.6.3.4 Strategic Initiatives
  • 9.6.4 BD
    • 9.6.4.1 Company overview
    • 9.6.4.2 Financial performance
    • 9.6.4.3 Product benchmarking
    • 9.6.4.4 Strategic Initiatives
  • 9.6.5 BIOMERIEUX
    • 9.6.5.1 Company overview
    • 9.6.5.2 Financial performance
    • 9.6.5.3 Product benchmarking
    • 9.6.5.4 Strategic Initiatives
  • 9.6.6 Creative Diagnostics
    • 9.6.6.1 Company overview
    • 9.6.6.2 Financial performance
    • 9.6.6.3 Product benchmarking
    • 9.6.6.4 Strategic Initiatives
  • 9.6.7 Hi-Media Laboratories Pvt. Ltd.
    • 9.6.7.1 Company overview
    • 9.6.7.2 Financial performance
    • 9.6.7.3 Product benchmarking
    • 9.6.7.4 Strategic initiatives
  • 9.6.8 PerkinElmer, Inc.
    • 9.6.8.1 Company overview
    • 9.6.8.2 Financial performance
    • 9.6.8.3 Product benchmarking
    • 9.6.8.4 Strategic initiatives
  • 9.6.9 ELITechGroup
    • 9.6.9.1 Company overview
    • 9.6.9.2 Financial performance
    • 9.6.9.3 Product benchmarking
    • 9.6.9.4 Strategic initiatives
  • 9.6.9 F. Hoffmann-La Roche Ltd
    • 9.6.9.1 Company overview
    • 9.6.9.2 Financial performance
    • 9.6.9.3 Product benchmarking
    • 9.6.9.4 Strategic initiatives